4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-19-046714
SVP & Chief Scientific Officer sold 3,245 shares at $18.15 ($58,897)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Doberstein Stephen K SVP & Chief Scientific Officer | 2019-08-16 | Sale | −3,245 | $18.15 | $58,897 | 92,668 | D: show line 1 in the form |
| Open-market sales · 3,245 sh · avg $18.15 · $58,897 | |||||||
Loading xslF345X03/doc4.xml…